AMSTERDAM, July 16, 2012 /PRNewswire/ --
Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced the launch of a structured Product Literature Database (PLD) solution for professionals in the life sciences. The PLD solution is a further development of the QUOSA literature management solution and it enables a higher level of scalability, automation and usability. QUOSA, a content management and workflow productivity solutions provider, was acquired by Elsevier in January 2012.
PLDs are centralized repositories of product-related scientific literature maintained by life sciences institutions to meet regulatory reporting requirements, address medical inquiries and inform progress in product development. PLDs are used by a broad array of groups within life science institutions who need to access public information related to their company's and competitor's products. PLDs primarily contain information from journal and conference abstracts as well as some other public sources, for example media articles.
Michael Rai, General Manager of QUOSA at Elsevier, said, "We have recognized content management and workflow productivity to be a key strategic area in life sciences to support. Our new PLD solution both compliments our current content sources like Embase and extends ourselves to better support the workflows of end users in, for example, medical affairs and pharmacovigilance groups. We are actively engaging in end user discussions to help define how we can take the QUOSA key product components and develop superior workflow solutions for improved post market surveillance."
Elsevier has tailored and upgraded QUOSA's solution to serve the specific needs of life sciences professionals such as pharmacovigilance and medical affairs personnel in pharma, biotech and medical device companies. New functionalities include:
These new features complement existing QUOSA functionality which is also essential to the PLD solution:
Please visit the QUOSA Product Literature Database web page for more information.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, MD Consult and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Copyright©2012 PR Newswire.
All rights reserved